Skip to main content
. 2001 Jun;51(6):567–576. doi: 10.1046/j.0306-5251.2001.01396.x

Table 3.

Models tested for factors influencing carbamazepine clearance in the preliminary step.

Models AIC SC
1. f(A,W,G,R,FM,PB,PH,PN) 1897.686 1931.079
2. f(A,W,G,R,FM,PB,PH) 1895.751 1925.435
3. f(A,W,G,R,PB,PH) 1893.736 1919.709
4. f(A,W, R,PB,PH) 1891.780 1914.152
5. f(A,W,PB,PH) 1889.936 1908.488
6. f(A,W,PB) 1888.015 1902.857
7. f(W,PB) 1906.691 1917.822
8. f(A,W) 1906.778 1917.879
9. f(A,PB) 1955.311 1966.442
10. f(W) 1940.617 1948.038
11. f(PB) 1953.311 1960.732
12. f(A) 1980.848 1988.269

A = age; W = weight; G = gender; R = race; FM = formulation

PB = presence of phenobarbitone; PH = presence of phenytoin

PN = presence of nonanticonvulsants; AIC = Akaike Information Criteria

SC = Schwartz Criteria.